[Use of intravenous iron in chronic renal patients with anemia. Higher levels of hemoglobin at a lower cost].
It is presented the experience with 90 patients receiving Eritropoietin s.c. and oral iron who were in chronic haemodialysis. After basic laboratories, including iron kinetic, in all of them was stopped oral iron and started i.v. iron 60 mgs per week, but keeping the same eritropoietin doses. The results showed an increased haemoglobin level from 6.5 to 11 g/dl mean values and a decreased doses of eritropoietin between 25 to 50%. This represent an important elevation of haemoglobin levels at a significant low cost.
Cuero
C J
CJ
Servicio de Nefrología, Complejo Hospitalario Metropolitano, Caja de Seguro Social Dr, Arnulfo Arias Madrid.
Pérez
E
E
de Rivera
C
C
D000293:Adolescent; D000328:Adult; D018798:Anemia, Iron-Deficiency / Q000188:drug therapy* / Q000209:etiology*; D002908:Chronic Disease; D003365:Costs and Cost Analysis; D004921:Erythropoietin / Q000008:administration & dosage* / Q000191:economics*; D006454:Hemoglobins / Q000032:analysis* / Q000191:economics*; D006801:Humans; D007275:Injections, Intravenous; D007501:Iron / Q000008:administration & dosage*; D007676:Kidney Failure, Chronic / Q000150:complications*; D008875:Middle Aged
D006454:Hemoglobins; D004921:Erythropoietin; D007501:Iron